Literature DB >> 1733134

Results of surgery: long-term effects on hyperlipidemia.

J J Gleysteen1.   

Abstract

To define frequency of lipid abnormalities and to monitor improvement or correction of those abnormalities postoperatively, 66 patients with chronic morbid obesity had total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride determinations preoperatively and at staged intervals up to 5-7 y after Roux-Y gastric bypass. Preoperative abnormal HDL-cholesterol and triglyceride concentrations were frequent. Major improvements occurred in these lipid concentrations by 6 mo postoperatively, and some further improvements occurred with additional weight loss at 1 y. At 5-7 y, among 33 patients, raised concentrations of HDL cholesterol were upheld in women (P less than 0.01); reductions in triglycerides were maintained in men (P less than 0.025); and reduced total cholesterol:HDL-cholesterol, which was achieved by 6 mo, was sustained in both men and women (P less than 0.01). In comparing lipid profiles of gastric surgery through 5 y with recent data from the surgical arm of the Program on Surgical Control of the Hyperlipidemias (POSCH), postulates are made of anticipated reduction in morbid, and even fatal, cardiac events in the operated morbidly obese population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733134     DOI: 10.1093/ajcn/55.2.591s

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  15 in total

1.  Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study.

Authors:  Stephen L Wasmund; Theophilus Owan; Frank G Yanowitz; Ted D Adams; Steven C Hunt; Mohamed H Hamdan; Sheldon E Litwin
Journal:  Heart Rhythm       Date:  2010-10-20       Impact factor: 6.343

2.  National trends in utilization and outcomes of bariatric surgery.

Authors:  T L Trus; G D Pope; S R G Finlayson
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

3.  Open versus laparoscopic adjustable silicone gastric banding: a prospective randomized trial for treatment of morbid obesity.

Authors:  L T de Wit; L Mathus-Vliegen; C Hey; B Rademaker; D J Gouma; H Obertop
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

4.  Long-term Management of Patients After Weight Loss Surgery.

Authors:  William S Richardson; Amber M Plaisance; Laura Periou; Jennifer Buquoi; Deanna Tillery
Journal:  Ochsner J       Date:  2009

5.  Surgical caloric restriction ameliorates mitochondrial electron transport dysfunction in obese females.

Authors:  Jing Li; Ritchie J Feuers; Varsha G Desai; Sherry M Lewis; Peter H Duffy; Martha A Mayhugh; George Cowan; Cynthia K Buffington
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

6.  Nephrolithiasis after bariatric surgery for obesity.

Authors:  John C Lieske; Rajiv Kumar; Maria L Collazo-Clavell
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

7.  Alterations in proinsulin and insulin dynamics, HDL Cholesterol and ALT after gastric bypass surgery. A 42-months follow-up study.

Authors:  Hans-Erik Johansson; Arvo Haenni; Margareta Ohrvall; Magnus Sundbom; Björn Zethelius
Journal:  Obes Surg       Date:  2009-02-20       Impact factor: 4.129

8.  Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content.

Authors:  Eva Pardina; Juan A Baena-Fustegueras; Roberto Catalán; Rosa Galard; Albert Lecube; Jose M Fort; Helena Allende; Víctor Vargas; Julia Peinado-Onsurbe
Journal:  Obes Surg       Date:  2008-10-30       Impact factor: 4.129

9.  The effect of laparoscopic gastric bypass on dyslipidemia in severely obese patients: a 5-year follow-up analysis.

Authors:  Jill S Ties; Jonathan A Zlabek; Kara J Kallies; Mohammed Al-Hamadini; Shanu N Kothari
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

10.  Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis.

Authors:  Eva Pardina; Juan A Baena-Fustegueras; Rafael Llamas; Roberto Catalán; Rosa Galard; Albert Lecube; Jose M Fort; Miquel Llobera; Helena Allende; Víctor Vargas; Julia Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-03-20       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.